HUYA Bioscience International has announced a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is said to be another in a series of collaborations that HUYA has established with China\'s leading research and development institutions to enable and accelerate the global development and commercialization of novel biopharmaceutical product opportunities originating in China.
HUYA is said to be one of the first companies to have recognized China\'s potential to help meet the global need for new pre-clinical and clinical stage compounds. The agreement with Ocean University of China provides HUYA with rights of first review and negotiation relating to certain novel therapeutic and diagnostic product candidates owned or controlled by the University. In return, Ocean University of China gains access to HUYA\'s global network of pharmaceutical partners and its expertise in pre-clinical and clinical development.
â€śOcean University is one of China\'s leading institutions, with considerable expertise in the field of marine pharmaceutical science,\" said Dr Michael Newman, Executive Vice President of Oncology at HUYA Bioscience. \"We look forward to collaborating with this prestigious university to bring novel biopharmaceutical products to the global marketplace.â€ť
â€śOcean University is committed to strengthening its research programs in marine pharmaceutical science,\" said Dr Qiangming Wu, Executive Dean, School of Medicine and Pharmacy, Ocean University of China. \"We are pleased to partner with HUYA\'s expert team to achieve this objective.â€ť